Savage resident Edwin Tan spent his summer carrying a message across the triathlon finish line. Tan, 29, lives with chronic hepatitis B. He said there isn’t a lot of public ...
X Studies in animals or humans have demonstrated fetal abnormalities ... U.S. Food and Drug Administration; HBV, hepatitis B virus. For the past 5 years, Dr. Calvin Q. Pan has received research ...
The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.
The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...
Hosted on MSN20d
FDA breakthrough status for Bluejay’s CHD therapy brelovitugBreakthrough therapy designation recognises the potential of brelovitug to transform the lives of people living with CHD. We look forward to initiating a global pivotal trial a ...
A new study published in the journal of Nature Scientific Reports found that anemia was almost three times as common in women ...
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).
The "Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the risk factors, comorbidities, ...
About Brelovitug (also known as BJT-778) Brelovitug is a high potency, fully human immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that targets the surface antigen (anti-HBsAg) of the hepatitis B ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback